(111) demonstrated that anti-PD-L1 antibodies reduced PD-1 expression on CD8+ T cells while increasing CTLA-4 in tumor-infiltrating lymphocytes (TILs), suggesting complementary roles in suppressing CTL responses. Here, CTLA4 is linked to neoplasm.